MedPath

Clinical study to evaluate the efficacy of Tapentadol nasal spray in patients undergoing below umbilical surgery under Spinal Anesthesia.

Phase 4
Conditions
Health Condition 1: - Health Condition 2: N838- Other noninflammatory disorders ofovary, fallopian tube and broad ligamentHealth Condition 3: R398- Other symptoms and signs involvingthe genitourinary system
Registration Number
CTRI/2024/03/064850
Lead Sponsor
Bangalore Medical College and Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients who have given written informed consent.

2. Patients aged 18-60 years.

3. Sex- males and females.

4. Patients scheduled for elective infraumblical surgery under spinal

anesthesia.

5. Patients with ASA grade I & II.

Exclusion Criteria

1. Patients not willing to give consent and refusing to participate in the study.

2. Patients with any contraindications for neuraxial blockade.

3. Known allergy to any of the study medication.

4. Patient on Opioid dependence.

5. Patients who have taken any medication by intranasal route within the past 72

hours prior to randomization.

6. Patients with severe bronchial asthma, paralytic ileus, nasal allergy, upper

respiratory tract infection.

7. Patients with current history of psychiatric illness and being treated with

tricyclic antidepressants, selective serotonin reuptake inhibitors, selective

noradrenaline reuptake inhibitors, anticonvulsants, neuroleptics, triptans,

monoamine oxidase inhibitors, steroids , a-2 agonists or opioid medications

within 28 days before scheduled surgery.

8. Patient with any end organ dysfunction.

9. Pregnancy.

10. Patient with history of alcohol abuse, smoking habit, drug abuse.

11. Uncontrolled cases of diabetes mellitus, hypertension, ischemic heart disease,

arrhythmias.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath